Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Expenses (2016 - 2017)

Tenax Therapeutics' Accumulated Expenses history spans 7 years, with the latest figure at $1.7 million for Q2 2017.

  • For Q2 2017, Accumulated Expenses changed N/A year-over-year to $1.7 million; the TTM value through Jun 2017 reached $1.7 million, changed N/A, while the annual FY2016 figure was $5.2 million, N/A changed from the prior year.
  • Accumulated Expenses for Q2 2017 was $1.7 million at Tenax Therapeutics, down from $3.6 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $5.2 million in Q4 2016 and bottomed at $64215.0 in Q3 2014.
  • The 5-year median for Accumulated Expenses is $1.3 million (2014), against an average of $1.5 million.
  • The largest annual shift saw Accumulated Expenses crashed 93.72% in 2015 before it soared 4567.76% in 2017.
  • A 5-year view of Accumulated Expenses shows it stood at $92060.0 in 2013, then surged by 1316.57% to $1.3 million in 2014, then surged by 138.08% to $3.1 million in 2015, then skyrocketed by 68.95% to $5.2 million in 2016, then plummeted by 68.03% to $1.7 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Accumulated Expenses are $1.7 million (Q2 2017), $3.6 million (Q1 2017), and $5.2 million (Q4 2016).